• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Provectus Biopharmaceuticals Inc

+ Add to Watchlist

PXY:GR

0.687 EUR 0.007 1.03%

As of 13:35:43 ET on 12/19/2014.

Snapshot for Provectus Biopharmaceuticals Inc (PXY)

Open: 0.667 Day's Range: 0.661 - 0.687 Volume: 0
Previous Close: 0.680 52wk Range: 0.591 - 0.950 1-Yr Rtn: -

Stock Chart for PXY

No chart data available.
  • PXY:GR 0.687
  • 1M
  • 1Y
0.680
Interactive PXY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PXY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 123.87
Shares Outstanding (M) 180.30
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PXY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PXY

Provectus Biopharmaceuticals, Inc. researches and develops pharmaceutical products and therapies. The Company develops therapies designed to target and destroy melanoma, liver and breast cancer as well as treat psoriasis and atopic dermatitis.

H Craig DeesChairman/CEOTimothy C ScottPresident
Peter R CulpepperCFO/COO/SecretaryEric A WachterChief Technology Officer
More Company Profile & Key Executives for PXY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil